jolkinolide b has been researched along with bn 52020 in 1 studies
| Studies (jolkinolide b) | Trials (jolkinolide b) | Recent Studies (post-2010) (jolkinolide b) | Studies (bn 52020) | Trials (bn 52020) | Recent Studies (post-2010) (bn 52020) |
|---|---|---|---|---|---|
| 35 | 0 | 27 | 14 | 0 | 5 |
| Protein | Taxonomy | jolkinolide b (IC50) | bn 52020 (IC50) |
|---|---|---|---|
| Glycine receptor subunit alpha-1 | Homo sapiens (human) | 1.8032 | |
| Glycine receptor subunit alpha-2 | Homo sapiens (human) | 2.0476 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 3.8 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 3.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinghorn, AD; Ren, Y | 1 |
1 other study(ies) available for jolkinolide b and bn 52020
| Article | Year |
|---|---|
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Diterpenes; Humans; Neoplasms; Sesquiterpenes; Structure-Activity Relationship; Triterpenes | 2020 |